3933.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 17:08):

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...

Stats
本日の出来高	2.85M
平均出来高	4.02M
時価総額	16.77B
EPS	HKD0 ( 2024-03-26 )
Last Dividend	HKD0.131 ( 2023-09-14 )
Next Dividend	HKD0 ( N/A )
P/E	5.63
ATR14	HKD0.00700 (0.08%)

ボリューム相関

長: 0.04 (neutral)

短: -0.25 (neutral)

Signal:(42.349) Neutral

United Laboratories 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

United Laboratories 相関 - 通貨/商品

-0.36
( neutral )

-0.17
( neutral )

0.00
( neutral )

-0.18
( neutral )

0.29
( neutral )

United Laboratories 財務諸表

Annual	2023
収益:	HKD13.74B
総利益:	HKD6.33B (46.11 %)
EPS:	HKD1.490

FY	2023
収益:	HKD13.74B
総利益:	HKD6.33B (46.11 %)
EPS:	HKD1.490

FY	2022
収益:	HKD11.33B
総利益:	HKD4.97B (43.84 %)
EPS:	HKD0.870

FY	2021
収益:	HKD9.70B
総利益:	HKD4.21B (43.40 %)
EPS:	HKD0.560

Financial Reports:

No articles found.

United Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0801 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.196 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

United Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.52 - Stable (9.57%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.156	2008-05-26
Last Dividend	HKD0.131	2023-09-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	15	--
Total Paid Out	HKD1.398	--
Avg. Dividend % Per Year	0.00%	--
Score	2.66	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.52
Div. Directional Score	7.71	--

Next Divdend (Est)
(2024-11-19)

HKD0.150 Estimate 2.95 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.66

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%
8053.HK	No Dividend Player	2023-09-28	Annually	0.00%
2001.HK	Ex Dividend Knight	2023-09-01	Annually	0.00%
1072.HK	Ex Dividend Junior	2023-06-30	Sporadic	0.00%
0151.HK	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
3669.HK	Ex Dividend Junior	2023-09-07	Annually	0.00%
1635.HK	Ex Dividend Junior	2023-06-30	Annually	0.00%
0686.HK	Ex Dividend Junior	2023-06-29	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.197	1.500	6.07	9.10	[0 - 0.5]
returnOnAssetsTTM	0.129	1.200	5.72	6.86	[0 - 0.3]
returnOnEquityTTM	0.223	1.500	8.64	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.08	0.800	4.60	3.68	[1 - 3]
quickRatioTTM	1.528	0.800	5.72	4.57	[0.8 - 2.5]
cashRatioTTM	0.643	1.500	7.54	10.00	[0.2 - 2]
debtRatioTTM	0.0714	-1.500	8.81	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.659	2.00	9.78	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.400	2.00	9.80	10.00	[0 - 20]
debtEquityRatioTTM	0.118	-1.500	9.53	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.461	1.000	5.65	5.65	[0.2 - 0.8]
operatingProfitMarginTTM	0.231	1.000	7.38	7.38	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.798	1.000	6.68	6.68	[0.2 - 2]
assetTurnoverTTM	0.654	0.800	8.98	7.18	[0.5 - 2]
Total Score				10.90

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.74	1.000	9.52	0	[1 - 100]
returnOnEquityTTM	0.223	2.50	9.12	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.400	2.00	9.87	10.00	[0 - 30]
dividendYielPercentageTTM	2.30	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.659	2.00	9.78	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.101	1.500	-2.66	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0872	1.000	-0.321	0	[0.1 - 0.5]
Total Score				4.52

United Laboratories

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.